Correlation Between Acumen Pharmaceuticals and Cns Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Cns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Cns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Acumen Pharmaceuticals and Cns Pharmaceuticals, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Cns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Cns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Cns Pharmaceuticals.

Diversification Opportunities for Acumen Pharmaceuticals and Cns Pharmaceuticals

-0.08

Correlation Coefficient

Acumen Pharmaceuticals  Cns Pharmaceuticals

Good diversification

The 3 months correlation between Acumen and Cns is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Cns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cns Pharmaceuticals and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Cns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cns Pharmaceuticals has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Cns Pharmaceuticals go up and down completely randomly.

Pair Corralation between Acumen Pharmaceuticals and Cns Pharmaceuticals

Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to under-perform the Cns Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Acumen Pharmaceuticals is 1.06 times less risky than Cns Pharmaceuticals. The stock trades about -0.17 of its potential returns per unit of risk. The Cns Pharmaceuticals is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  11.00  in Cns Pharmaceuticals on September 4, 2024 and sell it today you would earn a total of  0.00  from holding Cns Pharmaceuticals or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Acumen Pharmaceuticals  vs.  Cns Pharmaceuticals

Acumen Pharmaceuticals

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Acumen Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Acumen Pharmaceuticals is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Cns Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cns Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Acumen Pharmaceuticals and Cns Pharmaceuticals

The main advantage of trading using opposite Acumen Pharmaceuticals and Cns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Cns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cns Pharmaceuticals will offset losses from the drop in Cns Pharmaceuticals' long position.

The idea behind Acumen Pharmaceuticals and Cns Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..